Caricamento...
(68)Ga-DOTA-Affibody Molecule for In Vivo Assessment of HER2/neu Expression with PET
PURPOSE: Overexpression of HER2/neu in breast cancer is correlated with poor prognosis. It may vary between primary tumors and metastatic lesions and change during the treatment. Therefore, there is a need for new means to assess HER2/neu expression in vivo. In this work, we used 68Ga-labeled DOTA-Z...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3393017/ https://ncbi.nlm.nih.gov/pubmed/21748382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-011-1810-4 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|